Azithromycin Prices In USA
- United States: 122750 USD/MT (Azithromycin Dihydrate) US, FDA
The azithromycin prices in the USA for Q4 2023 reached 1,22,750 USD/MT in December.
The latest report by IMARC Group, titled "Azithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data," provides a thorough examination of the Azithromycin Prices. This report delves into the price of Azithromycin globally, presenting a detailed analysis, along with informative Azithromycin Price Chart. Through comprehensive Azithromycin Price analysis, the report sheds light on the key factors influencing these trend. Additionally, it includes historical data to offer context and depth to the current pricing landscape. The report also explores the Azithromycin Demand, analyzing how it impacts Industry dynamics. To aid in strategic planning, the price forecast section provides insights into price forecast, making this report an invaluable resource for industry stakeholders.
Azithromycin Prices Analysis
- China: 120000 USD/MT (Azithromycin Dihydrate) US, FDA
- Germany: 122195 USD/MT (Azithromycin Dihydrate) US, FDA
Report Offering:
- Monthly Updates - Annual Subscription
- Quarterly Updates - Annual Subscription
- Biannually Updates - Annual Subscription
The study delves into the factors affecting Azithromycin price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.
The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.
Request For a Sample Copy of the Report: https://www.imarcgroup.com/azithromycin-pricing-report/requestsample
Azithromycin Price Trend- Last Quarter
The extensive demand in the pharmaceutical industry for effective antimicrobial agents represents one of the key factors driving the market growth of azithromycin worldwide. Moreover, the increasing prevalence of bacterial infections and the need for broad-spectrum antibiotics are becoming increasingly popular, which is a major growth-inducing factor. In addition to this, the healthcare sector is expanding at a rapid pace, which includes the use of azithromycin in treating a variety of infections, thereby significantly contributing to the market growth.
Besides this, consumers are more interested in effective and quick treatment options which, in turn, is propelling the market growth. Apart from this, significant technological progress in drug formulation and delivery methods is bolstering the market growth. Additionally, the increased usage of azithromycin in combination therapies for more effective results is stimulating the market growth. Furthermore, customization of antibiotic treatment plans to suit individual patient needs is becoming increasingly popular.
The expanding use for azithromycin in travel medicine, especially for travelers to areas with a high prevalence of bacterial infections, is boosting the market growth globally. The increasing concern over antibiotic resistance is one of the pivotal factors driving the market growth of azithromycin worldwide. Moreover, key pharmaceutical companies are increasing their investments in research and developmental (R&D) activities to enhance azithromycin's efficacy and reduce its side effects, which, in turn, is propelling the market growth.
Azithromycin Industry Analysis
In the last quarter of 2023, the azithromycin market experienced fluctuations across various global regions, influenced by a confluence of economic, geopolitical, and sector-specific factors. In North America, particularly in the United States, azithromycin prices witnessed notable variations, initially marked by a significant decrease. This trend was largely driven by subdued domestic demand and an oversupply in the market, with merchants holding abundant inventories.
A crucial factor contributing to the diminished demand was the impact of inflation and interest rates, alongside geopolitical tensions that fostered a bearish market sentiment. The strength of the dollar played a significant role as well, making imports more affordable and thereby ensuring a plentiful supply that further pressured prices downward. However, there was a brief uptick in prices as signs of easing inflation appeared, suggesting a temporary shift in consumer spending habits that momentarily bolstered demand for azithromycin.
This increase was short-lived, as December saw a reduction in prices due to continued low demand, with market participants aiming to destock older inventories, culminating in a quarter-over-quarter price decrease.
Similarly, the azithromycin market in the APAC region, particularly in China, underwent significant price adjustments influenced by a variety of factors. October saw a decline in azithromycin prices, attributed to reduced demand from end sectors and an oversupply within the domestic market. The contraction of China's manufacturing sector, further exacerbated by an extended national holiday, signaled a weakened domestic demand that contributed to the initial price drop.
However, a subsequent improvement in market sentiment was observed in November, fueled by expanded supply-demand dynamics, improved logistics, and increased purchasing quantities, particularly from the healthcare sector amid the winter season. Despite these positive indicators, December witnessed a pronounced decrease in prices, driven by reduced new order inquiries and a growing concern over antibiotic resistance.
This concern over the efficacy of azithromycin, due to its overuse, led to a decreased demand as consumers sought alternative treatments, illustrating the complex interplay of health, economic, and supply chain dynamics influencing market prices.
Regional Price Analysis:
- Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand
- Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
- North America: United States and Canada
- Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
- Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco
Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
